4,453
Views
33
CrossRef citations to date
0
Altmetric
Original Research

Identification of a costimulatory molecule-based signature for predicting prognosis risk and immunotherapy response in patients with lung adenocarcinoma

, , , , , , , & show all
Article: 1824641 | Received 24 Apr 2020, Accepted 14 Sep 2020, Published online: 29 Sep 2020

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.